Fig. 1From: No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based studySurvival of women with breast cancer stage I–III and medication with aspirin after diagnosis. Blue line, no aspirin use 3–9 months after diagnosis; red line, aspirin use 3–9 months after diagnosis. 2Adjusted for age at diagnosis, stage, year of diagnosis, education level, region, comorbidity and aspirin use before diagnosisBack to article page